Next Article in Journal
Ageing with HIV
Previous Article in Journal
A Randomized Controlled Trial to Investigate the Effectiveness of the Prevention of Aspiration Pneumonia Using Recommendations for Swallowing Care Guided by Ultrasound Examination
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessArticle
Healthcare 2018, 6(1), 16; https://doi.org/10.3390/healthcare6010016

The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic

Economist and Independent Researcher, https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=895329
Received: 11 September 2017 / Revised: 11 December 2017 / Accepted: 22 December 2017 / Published: 13 February 2018

Abstract

1 million people are predicted to get infected with Lyme disease in the USA in 2018. Given the same incidence rate of Lyme disease in Europe as in the USA, then 2.4 million people will get infected with Lyme disease in Europe in 2018. In the USA by 2050, 55.7 million people (12% of the population) will have been infected with Lyme disease. In Europe by 2050, 134.9 million people (17% of the population) will have been infected with Lyme disease. Most of these infections will, unfortunately, become chronic. The estimated treatment cost for acute and chronic Lyme disease for 2018 for the USA is somewhere between 4.8 billion USD and 9.6 billion USD and for Europe somewhere between 10.1 billion EUR and 20.1 billion EUR. If governments do not finance IV treatment with antibiotics for chronic Lyme disease, then the estimated government cost for chronic Lyme disease for 2018 for the USA is 10.1 billion USD and in Europe 20.1 billion EUR. If governments in the USA and Europe want to minimize future costs and maximize future revenues, then they should pay for IV antibiotic treatment up to a year even if the estimated cure rate is as low as 25%. The cost for governments of having chronic Lyme patients sick in perpetuity is very large. View Full-Text
Keywords: Borrelia; Lyme disease; chronic Lyme disease; ILADS; incidence rate; cost chronic Lyme disease; CDC Borrelia; Lyme disease; chronic Lyme disease; ILADS; incidence rate; cost chronic Lyme disease; CDC
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Davidsson, M. The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic. Healthcare 2018, 6, 16.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Healthcare EISSN 2227-9032 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top